期刊
JOURNAL OF FUNGI
卷 7, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/jof7100786
关键词
bioactive compounds; endophytic fungi; natural products; secondary metabolites
资金
- Singapore Institute of Food and Biotechnology Innovation, Agency for Science, Technology and Research (A*STAR), Singapore
Fungi have long served as repositories of bioactive secondary metabolites and the demand for new drugs is increasing. Exploring understudied and specialized microbes is a promising way to discover potential new drug lead compounds. Plant-associated fungi known as endophytes, with unique bioactive compounds, have emerged as an important source for drug discovery.
For years, fungi have served as repositories of bioactive secondary metabolites that form the backbone of many existing drugs. With the global rise in infections associated with antimicrobial resistance, in addition to the growing burden of non-communicable disease, such as cancer, diabetes and cardiovascular ailments, the demand for new drugs that can provide an improved therapeutic outcome has become the utmost priority. The exploration of microbes from understudied and specialized niches is one of the promising ways of discovering promising lead molecules for drug discovery. In recent years, a special class of plant-associated fungi, namely, fungal endophytes, have emerged as an important source of bioactive compounds with unique chemistry and interesting biological activities. The present review focuses on endophytic fungi and their classification, rationale for selection and prioritization of host plants for fungal isolation and examples of strategies that have been adopted to induce the activation of cryptic biosynthetic gene clusters to enhance the biosynthetic potential of fungal endophytes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据